|
2009 Journal Article Antibody to the dendritic cell surface activation antigen CD83 prevents acute graft-versus-host disease: Figure 6Wilson, John, Cullup, Hannah, Lourie, Rohan, Sheng, Yonghua, Palkova, Anna, Radford, Kristen J., Dickinson, Anne M., Rice, Alison M., Hart, Derek N.J. and Munster, David J. (2009). Antibody to the dendritic cell surface activation antigen CD83 prevents acute graft-versus-host disease: Figure 6. The Journal of Experimental Medicine, 206 (5), 1203-1203. doi: 10.1084/jem.20070723041509c |
|
2009 Conference Publication CD83 antibody prevents GvHD and does not impair GvL inductionCullup, H., Wilson, J., Lourie, R., Shen, Y., Palkova, A., Radford, K., Dickinson, A. M., Rice, A., Hart, D. and Munster, D. (2009). CD83 antibody prevents GvHD and does not impair GvL induction. 35th Annual Meeting of the European-Group-for-Blood-and-Marrow-Transplantation, Goteborg Sweden, Mar 29-Apr 01, 2009. LONDON: NATURE PUBLISHING GROUP. |
|
2009 Journal Article Antibody to the dendritic cell surface activation antigen CD83 prevents acute graft-versus-host diseaseWilson, John, Cullup, Hannah, Lourie, Rohan, Sheng, Yonghua, Palkova, Anna, Radford, Kristen J., Dickinson, Anne M., Rice, Alison M., Hart, Derek N. J. and Munster, David J. (2009). Antibody to the dendritic cell surface activation antigen CD83 prevents acute graft-versus-host disease. Journal of Experimental Medicine, 206 (2), 387-398. doi: 10.1084/jem.20070723 |
|
2008 Book Chapter Dendritic Cells in Cancer ImmunotherapyVulink, A., Radford, K. J., Melief, C. and Hart, D. N. J. (2008). Dendritic Cells in Cancer Immunotherapy. Advances in Cancer Research. (pp. 363-407) London, U.K.: Elsevier Inc.. doi: 10.1016/S0065-230X(07)99006-5 |
|
2007 Conference Publication Residual lymphocytes in GM-CSF and IL-15 differentiated monocyte-derived dendritic cells enables cytotoxic T lymphocyte responsesHardy, Melinda Y., Kassianos, Andrew J., Wilkinson, Ray, Vulink, Anneie, Hart, Derek N. J. and Radford, Kristen J. (2007). Residual lymphocytes in GM-CSF and IL-15 differentiated monocyte-derived dendritic cells enables cytotoxic T lymphocyte responses. 49th Annual Meeting of the American-Society-of-Hematology, Atlanta Ga, Dec 08-11, 2007. WASHINGTON: AMER SOC HEMATOLOGY. |
|
2007 Journal Article Blood monocytes, myeloid dendritic cells and the cytokines interleukin (IL)-7 and IL-15 maintain human CD4(+) T memory cells with mixed helper/regulatory functionMcKinlay, Adam, Radford, Kristen, Kato, Masato, Field, Ken, Gardiner, Damien, Khalil, Dalia, Burnell, Fiona, Hart, Derek and Vuckovic, Slavica (2007). Blood monocytes, myeloid dendritic cells and the cytokines interleukin (IL)-7 and IL-15 maintain human CD4(+) T memory cells with mixed helper/regulatory function. Immunology, 120 (3), 392-403. doi: 10.1111/j.1365-2567.2006.02515.x |
|
2007 Journal Article Enhanced delivery of immunoliposomes to human dendritic cells by targeting the multilectin receptor DEC-205Badiee, A., Davies, N. M., McDonald, K., Radford, K., Michiue, H., Hart, D. and Kato, M. (2007). Enhanced delivery of immunoliposomes to human dendritic cells by targeting the multilectin receptor DEC-205. Vaccine, 25 (25), 4757-4766. doi: 10.1016/j.vaccine.2007.04.029 |
|
2006 Journal Article Numerical and functional assessment of blood dendritic cells in prostate cancer patientsWilkinson, Ray, Kassianos, Andrew J., Swindle, Peter, Hart, Derek N. J. and Radford, Kristen J. (2006). Numerical and functional assessment of blood dendritic cells in prostate cancer patients. The Prostate, 66 (2), 180-192. doi: 10.1002/pros.20333 |
|
2006 Journal Article CD11c+ blood dendritic cells induce antigen-specific cytotoxic T lymphocytes with similar efficiency compared to monocyte-derived dendritic cells despite higher levels of MHC class I expressionRadford, Kristen J., Turtle, Cameron J., Kassianos, Andrew J. and Hart, Derek N. J. (2006). CD11c+ blood dendritic cells induce antigen-specific cytotoxic T lymphocytes with similar efficiency compared to monocyte-derived dendritic cells despite higher levels of MHC class I expression. Journal of Immunotherapy, 29 (6), 596-605. doi: 10.1097/01.cji.0000211310.90621.5d |
|
2005 Journal Article Vaccine strategies to treat lymphoproliferative disordersRadford, Kristen J., Vari, Frank and Hart, Derek N. J. (2005). Vaccine strategies to treat lymphoproliferative disorders. Pathology, 37 (6), 534-550. doi: 10.1080/00313020500376462 |
|
2005 Conference Publication Human memory CD4(+) T cells maintained in the absence of antigen develop regulatory T cells capable of suppressing antibody responsesMckinlay, A, Radford, KJ, Gardiner, D, Khalil, D, Field, K, Burnell, F, Hart, DNJ and Vuckovic, S (2005). Human memory CD4(+) T cells maintained in the absence of antigen develop regulatory T cells capable of suppressing antibody responses. 35th Annual SCientific Meeting of the Australasian-Society-for-Immunology/14th International HLA and Immunogenetics Workshops, Melbourne Australia, Nov 29-Dec 02, 2005. OXFORD: BLACKWELL PUBLISHING. |
|
2005 Conference Publication Production of IL-2, IL-12, and IL-10 by human blood myeloid dendritic cellsHardy, MY, Kassianos, AJ, Clark, GJ, Hart, DNJ and Radford, KJ (2005). Production of IL-2, IL-12, and IL-10 by human blood myeloid dendritic cells. 35th Annual SCientific Meeting of the Australasian-Society-for-Immunology/14th International HLA and Immunogenetics Workshops, Melbourne Australia, Nov 29-Dec 02, 2005. OXFORD: BLACKWELL PUBLISHING. |
|
2005 Journal Article Immunoselection of functional CMRF-56+ blood dendritic cells from multiple myeloma patients for immunotherapyRadford, Kristen J., Turtle, Cameron J., Kassianos, Andrew J., Vuckovic, Slavica, Gardiner, Damien, Khalil, Dahlia, Taylor, Kerry, Wright, Sue, Gill, Devinder and Hart, Derek N. J. (2005). Immunoselection of functional CMRF-56+ blood dendritic cells from multiple myeloma patients for immunotherapy. Journal of Immunotherapy, 28 (4), 322-331. doi: 10.1097/01.cji.0000163592.66910.e4 |
|
2004 Conference Publication RNA-loading of CMRF-56 positive blood dendritic cells is a promising strategy for multiple myeloma immunotherapyTurtle, C. J., Radford, K. J., Allan, C. P., Kassianos, A., Kato, M., Vuckovic, S., MacDonald, K.J., Lopez, Jose A., Jackson, D. C., Wright, S., Taylor, K., Marlton, P., Gill, D., Hart, D. N. J. and Korngold, R. (2004). RNA-loading of CMRF-56 positive blood dendritic cells is a promising strategy for multiple myeloma immunotherapy. Tandem BMT 2004 Meeting, Orlando, Florida, U.S., 13-17 February 2004. CHARLOTTESVILLE: AMER SOC HEMATOLOGY. doi: 10.1016/j.bbmt.2003.12.081 |
|
2004 Journal Article Potential therapeutic applications of recombinant, invasive E. coliCritchley, R, Jezzard, S, Radford, KJ, Goussard, S, Lemoine, NR, Grillot-Courvalin, C and Vassaux, G (2004). Potential therapeutic applications of recombinant, invasive E. coli. Gene Therapy, 11 (15), 1224-1233. doi: 10.1038/sj.gt.3302281 |
|
2003 Conference Publication RNA-loading of CMRF-56 positive blood dendritic cells is a promising strategy for multiple myeloma immunotherapy.Turtle, CJ, Radford, KJ, Allan, CP, Kato, M and Hart, DNJ (2003). RNA-loading of CMRF-56 positive blood dendritic cells is a promising strategy for multiple myeloma immunotherapy.. 45th Annual Meeting of the American-Society-of-Hematology, San Diego California, Dec 06-09, 2003. WASHINGTON: AMER SOC HEMATOLOGY. |
|
2003 Journal Article Recombinant E. coli efficiently delivers antigen and maturation signals to human dendritic cells: Presentation of MART1 to CD8+ T cellsRadford, KJ, Jackson, AM, Wang, JH, Vassaux, G and Lemoine, NR (2003). Recombinant E. coli efficiently delivers antigen and maturation signals to human dendritic cells: Presentation of MART1 to CD8+ T cells. International Journal of Cancer, 105 (6), 811-819. doi: 10.1002/ijc.11149 |
|
2002 Journal Article A recombinant E. coli vaccine to promote MHC class I-dependent antigen presentation: application to cancer immunotherapyRadford, K. J., Higgins, D. E., Pasquini, S., Cheadle, E. J., Carta, L., Jackson, A. M., Lemoine, N. R. and Vassaux, G. (2002). A recombinant E. coli vaccine to promote MHC class I-dependent antigen presentation: application to cancer immunotherapy. Gene Therapy, 9 (21), 1455-1463. doi: 10.1038/sj.gt.3301812 |
|
1997 Journal Article Immunogenicity of CD63 in a patient with melanomaSmith, Melanie, Bleijs, Rik, Radford, Kristen and Mersey, Peter (1997). Immunogenicity of CD63 in a patient with melanoma. Melanoma Research, 7 (SUPPL. 2) |
|
1997 Journal Article Regulation of tumor cell motility and migration by CD63 in a human melanoma cell lineRadford, KJ, Thorne, RF and Hersey, P (1997). Regulation of tumor cell motility and migration by CD63 in a human melanoma cell line. Journal of Immunology, 158 (7), 3353-3358. |
